Company Press Release: Compugen Launches LabOnWeb.com Internet
Research Engine for Life Scientists

Pioneering Capabilities To Enhance Experimental Research and Discovery

From Yahoo Biz Wire

JAMESBURG, N.J.--(BW HealthWire)--Jan. 12, 2000--Compugen announced today the launch of LabOnWeb.com (www.LabOnWeb.com), the Internet's first life sciences research engine.

The LabOnWeb platform integrates web-embedded knowledge into common experimental life science workflow to both enhance discovery and increase research productivity.

Among the leading institutions Beta-site testing LabOnWeb.com were Harvard University, New York University, UCSF, the Hebrew University in Jerusalem, Tel Aviv University and the Weizmann Institute of Science in Rehovot, Israel. Scientists at these institutions obtained full gene sequences within minutes rather than through laborious experimental sequence elongation procedures that often last for months or, in some cases, prove unsuccessful.

Utilizing proprietary data and analysis tools, LabOnWeb.com provides a vital experiment booster and enhancement engine. It significantly broadens access to scientific knowledge based on public and proprietary experimental data, computational research technologies, molecular biology techniques and the Internet's powerful channels of communications. LabOnWeb.com enhances gene exploration and discovery and provides users within the mobile life science community with access to the most comprehensive and up-to-date life science data and technology.

"With biology becoming increasingly computational and the Internet assuming a central role in communications, LabOnWeb.com is uniquely positioned to empower life scientists by providing them with new and unprecedented research opportunities over the web," said Compugen Chairman Martin Gerstel. "LabOnWeb.com will potentially facilitate new discovery techniques, boost researchers' productivity, save precious time and resources and shorten the healthcare discovery process," Gerstel noted. "Compugen will continue to provide web-embedded products through LabOnWeb.com that will further enhance the life sciences and enrich the store of human knowledge," he added.

In coming weeks, additional data and technologies will be added by Compugen, which is leading the LabOnWeb.com enterprise, and by additional partners.

About Compugen
Compugen, a life science research company, is a world leader in converging advanced computational technologies with molecular biology to model and understand the molecular mechanisms of life. Compugen's computational and biological capabilities are based on a multi-disciplinary research team consisting of mathematicians, computer scientists and molecular biologists.

In utilizing its computational biology technologies Compugen has created a pipeline of more than 4,000 novel human genes and an additional 10,000 novel sequences with identified putative functions. From this database, which is being enlarged on an on-going basis, selected genes with anticipated pharmaceutical relevance are being further developed by Compugen, using its in-house molecular biology capabilities, or licensed to other companies for development and commercialization.

The company's broad customer base includes, among others, Amgen, Bayer, Eli Lilly, HGS, Merck, Millennium, Monsanto, Parke-Davis, SKB, Wyeth-Ayerst, NIH, the San Diego Supercomputer Center and the US Patent and Trademark Office.

Back to list of news